| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition
PRECISE-AD Phase 1b clinical trial in Alzheimer’s patients remains on track for unblinded 12-month topline data in the first quarter of 2027, including full safety, biomarker and cognitive outcomes data |
| 12 Nov 2026 | SCHEDULE 13G |
| 12 Nov 2026 |
8-K: Regulation FD Disclosure
Copyright 2026, ProMIS Neurosciences Inc., Non-confidential L E G A L D I S C L O S U R E S Forward-Looking Statements & Disclaimers This slide deck may contain certain forward-looking information and “forward-looking statements” that ar... |
| 06 Nov 2026 |
Form 4: Williams Eugene, Director
Bought 26,500 shares ($90.9K) |
| 03 Nov 2026 |
Form 4: Williams Eugene, Director
Bought 1,316 shares ($5.25K) |
| 03 Nov 2026 |
Form 4: Cashman Neil, Director
Bought 10,000 shares ($38.6K) |
| 06 Oct 2026 |
Form 4: Rubino Ivana, Chief Commercial Officer
Granted 80,000 Option (right to buy) |
| 06 Oct 2026 |
Form 3: Rubino Ivana, Chief Commercial Officer
No securities owned |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 |
8-K: Results of Operations and Financial Condition
Announced positive blinded six-month interim safety and biomarker results from PRECISE-AD, the Company's Phase 1b trial of PMN310 in patients with early Alzheimer's disease (AD), including zero cases of amyloid-related imaging abnormalit... |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 07 Aug 2026 |
Form 4: Kaplan Johanne, Chief Development Officer
Bought 2,280 shares ($30.3K) |
| 28 Jul 2026 |
8-K: Regulation FD Disclosure; Other Events
PRECISE-AD PMN310 · PHASE 1b BLINDED 6-MONTH INTERIM ANALYSIS Safety & Biomarker Assessment Update Blinded Interim Analysis Topline results expected Q1 2027 1 |
| 29 May 2026 | S-8 |
| 22 May 2026 |
Form 4: Wyman William W, Director
Granted 16,500 Option (right to buy) |
| 22 May 2026 |
Form 4: Williams Eugene, Director
Granted 16,500 Option (right to buy) |
Loading...